Rehovot, Israel

Michael Sela

USPTO Granted Patents = 29 


 

Average Co-Inventor Count = 3.9

ph-index = 19

Forward Citations = 1,003(Granted Patents)


Location History:

  • Rechovot, IL (2009 - 2011)
  • Rehovot, IL (1978 - 2018)

Company Filing History:


Years Active: 1978-2018

Loading Chart...
Loading Chart...
Loading Chart...
29 patents (USPTO):Explore Patents

Sure, here's an article about inventor Michael Sela:

Title: Michael Sela: Pioneering Innovations in Biomedicine

Introduction:

Michael Sela, a renowned inventor in the field of biomedicine, hails from Rehovot, Israel. With an impressive number of 29 patents to his name, Sela has made significant contributions to the field of pharmaceutical compositions and novel antibody combinations.

Latest Patents:

1. Aptamers, Multimeric Aptamers, and Uses Thereof: Sela's latest patent introduces monomeric and multimeric aptamers, along with pharmaceutical compositions and methods for their use.

2. Antibody Combinations and Use for Treating Cancer: Sela's innovative method identifies combinations of antibodies with enhanced anti-tumor activity, specifically targeting ErbB-2 receptors. These novel antibody combinations show promise in cancer treatment.

Career Highlights:

Currently affiliated with the prestigious Harvard University, Sela continues to push the boundaries of innovation in biomedicine. His research and patents reflect a commitment to improving healthcare outcomes through cutting-edge technologies.

Collaborations:

Sela's impactful work is further amplified through collaborations with esteemed colleagues such as Ruth Arnon and Dvora Teitelbaum. Together, they form a formidable team driving advancements in the field of biomedicine.

Conclusion:

In conclusion, Michael Sela stands as a trailblazer in the realm of biomedicine, with a track record of pioneering inventions and patents that have the potential to transform cancer treatment and pharmaceutical compositions. His collaborations and career at Harvard University underscore his dedication to innovation and pushing the boundaries of scientific knowledge.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…